Dr. Joseph Eder

Biography

Dr. Joseph Eder is a principal clinical investigator with a prominent role in early clinical trials, particularly in high dose chemotherapy, drug resistance modulation, immune-oncology, and precision medicine. He began his career at Harvard, where he led key clinical programs and contributed to notable collaborations at the Dana-Farber Cancer Institute and other distinguished institutions. Dr. Eder served as the Clinical Director of the Experimental Therapeutics Program at Dana-Farber/Harvard Cancer Center, overseeing clinical trials and advancing cancer drug development. He later held the position of Medical Science Director at AstraZeneca, focusing on the development of chemical agents through clinical proof of concept. Dr. Eder's scholarly work includes numerous publications in the fields of clinical trials and cancer therapy, demonstrating his commitment to advancing oncology through rigorous scientific inquiry and collaborative research efforts.

Research Interests